Empower Clinics Names New General Manager of Medisure Laboratory
- Wall Street mixed; Dow pressured by selloff in Salesforce shares
- S&P 500 to re-test lows in H1 and then rally to 4200 on Fed pivot signal - JPMorgan
- Salesforce (CRM) drops after soft results, MS sees attractive valuation
- Snowflake (SNOW) falls as macro headwinds drag on guidance, analysts remain upbeat
- Piper Sandler says Apple (AAPL) likely lost 9M iPhone 14 units, cuts revenue estimates
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Eric Christian brings twenty years of experience in healthcare industry including scaling diagnostics laboratory
VANCOUVER, BC / ACCESSWIRE / November 24, 2022 / EMPOWER CLINICS INC (CSE:EPW)(OTCQB: EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, a medical device company and a high complexity medical diagnostics laboratory - announces that Eric Christian is the new General Manager at Medisure Labs.
Eric has twenty years of experience as a proven leader and entrepreneur - with both business development and operational expertise - in the medical industry. He has an established network of physicians throughout the Dallas/Fort Worth region. In his model of creating long term partnerships with physicians to service their needs, Eric has provided medical solutions including spine implants, allograft, biologics, and intraoperative neurophysiological monitoring.
Specifically in the diagnostic laboratory space, Eric was part the founding management team of a successful lab in Dallas - that counted 150 employees and processed 15,000 specimens per month- and played a key business and operational role to achieve rapid growth. He established and streamlined workflows and processes to build a solid foundation for growth. He engaged physicians throughout the Dallas region and co-developed new products and services that had immediate take up. Eric also played a key role in strategic acquisitions including the purchase of an ambulatory surgery centre. He has both MBA (2001) and BA (1999) in Political Science from Texas Tech University.
"I am very pleased that a leader of the caliber of Eric is joining our team to lead Medisure Labs," stated Steven McAuley, Chairman and CEO of Empower Clinics. "We stand to benefit immensely from his proven track record of scaling a diagnostics laboratory. With Eric at the helm, our entire team including shareholders can find renewed confidence in realizing the potential of our laboratory business and fulfilling synergies between MediSure's innovative at-home testing solutions, product development and its imminent US market entry. "
"There is an impressive foundation to build on at Medisure Labs," said Eric Christian, new General Manager of Medisure Labs. "I've visited and led many labs over the last two decades. I can confirm that Medisure Labs is one of the cleanest and well-designed state-of-the-art facilities that I have ever seen. It sits at a prime location in the heart of the Dallas medical district. Coupled with MediSure's at-home testing solutions, I'm incredibly excited to roll out unique health solutions for the US market that leverage both our in-house diagnostics and medical device capabilities. For these reasons I have accepted the challenge to lead the lab, immediately commence sales efforts to deliver on its revenue potential and join a team that can offer convenient integrated healthcare solutions to the U.S."
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Chief Executive Officer
Steven McAuley CEO
Business Development & Communications
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include statements regarding: the likelihood or ability for the Company to secure new testing business, that realizing the potential of the laboratory business and fulfilling synergies between MediSure's innovative at-home testing solutions, product development and its imminent US market entry will happen or be attained. Such forward-looking statements are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Company may be unable to enter into definitive agreements, or close transactions with respect to, proposed future clinic openings; that due diligence with respect to anticipated clinic openings and acquisitions may not be satisfactory to the Company; risks related to delays in permitting or construction; risks related to supply chains and access to labour; that legislative changes may have an adverse effect on the Company's business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; that the Company will be able to commence and/or complete build-outs and tenants improvements for new clinics; general business, economic, competitive, political and social uncertainties; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur on the terms or in the time expected, or at all, or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.
SOURCE: Empower Clinics Inc.
View source version on accesswire.com:
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CSPi to Announce Fiscal Fourth Quarter and Full Year Financial Results on December 6, 2022
- VoltServer Awarded the 2022 North American Intelligent Power Distribution Technology Innovation Leadership Award by Frost & Sullivan
- The Power Play by The Market Herald Releases New Interviews with Heritage Mining, INX Digital, Datametrex, Calima Energy, RDARS and Stakeholder Gold Discussing Their Latest News
Create E-mail Alert Related CategoriesAccesswire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!